FDCE

FDCE assesses consistency across multiple high-throughput compound screening and functional genomics datasets in cancer cell lines to identify concordant functional signals.


Key Features:

  • Dataset integration: Integration of nine compound screening datasets and three functional genomics datasets for joint analysis.
  • Direct consistency measures: Quantifies alignment between datasets to measure direct concordance.
  • Indirect consistency measures: Evaluates associations between functional data and copy number-adjusted gene expression data.
  • Multi-dataset assessment: Evaluates consistency across more than two datasets simultaneously rather than only pairwise comparisons.
  • Global data analysis: Uses entire datasets rather than selected feature subsets to reduce the risk of overlooking global inconsistencies.

Scientific Applications:

  • Functional data consistency assessment: Assess consistency of functional screening signals across compound screening and functional genomics datasets in cancer cell lines.
  • Therapeutic agent identification: Identify compounds with consistent responses across multiple datasets.
  • Target discovery: Link functional data with copy number-adjusted gene expression to support discovery of candidate targets.
  • Cross-dataset validation: Validate findings across diverse datasets to increase reliability of conclusions in cancer genomics studies.

Methodology:

Integration of nine compound screening datasets and three functional genomics datasets; computation of direct measures assessing alignment between datasets; computation of indirect measures evaluating associations between functional data and copy number-adjusted gene expression data.

Topics

Details

License:
GPL-3.0
Cost:
Free of charge
Tool Type:
web application
Operating Systems:
Mac, Linux, Windows
Programming Languages:
R
Added:
11/7/2021
Last Updated:
11/24/2024

Operations

Publications

Cai L, Liu H, Minna JD, DeBerardinis RJ, Xiao G, Xie Y. Assessing consistency across functional screening datasets in cancer cells. Bioinformatics. 2021;37(23):4540-4547. doi:10.1093/bioinformatics/btab423. PMID:34081116. PMCID:PMC8652113.

PMID: 34081116
PMCID: PMC8652113
Funding: - National Institutes of Health: P30CA142543, P50CA70907, R35CA22044901, R35GM136375 - Cancer Prevention and Research Institute of Texas: RP180805, RP190107

Links